Development of Inducible Leucine-rich Repeat Kinase 2 (LRRK2) Cell Lines for Therapeutics Development in Parkinson's Disease
Liang Huang(Georgetown University), Howard J. Federoff(Georgetown University)
Cited by 4
Related Papers
Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson’s Disease
|Frontiers in Aging Neuroscience|2017|338
A genome-wide association study in multiple system atrophy
|Neurology|2016|163
What success can teach us about failure: the plasma metabolome of older adults with superior memory and lessons for Alzheimer's disease
|Neurobiology of Aging|2016|85
The Endoplasmic Reticulum Stress Response Factor CHOP-10 Protects against Hypoxia-induced Neuronal Death
|Journal of Biological Chemistry|2010|56
Personality and Performance in Specific Neurocognitive Domains Among Older Persons
|American Journal of Geriatric Psychiatry|2017|55